Literature DB >> 652064

Investigations on the structure-activity relationships of verapamil.

R Mannhold, R Steiner, W Haas, R Kaufmann.   

Abstract

An investigation was carried out towards a qualitative and quantitative structure-activity relationship of verapamil based on an analysis of the frequency-dependent negative inotropic action exerted in cat papillary muscles by various groups of verapamil derivatives. (1) Substituents of the benzene ring near the asymmetric carbon atom and the isopropyl group were found to be no essential substituents for the frequency-dependent negative inotropic action of verapamil but to have a strong influence on the potency of the drug. (2) Both the tertiary amino nitrogen and the two benzene rings are essential for the frequency-dependent negative inotropic action of verapamil (3) The molecular importance of the N-methyl group is probably based on steric effects. (4) Investigations of the verapamil derivative H 1 revealed that a quaternization of the drug is followed by a total loss of effectiveness. (5) No significant correlation of the biological activity of verapamil derivatives with the partition coefficient P has been obtained. (6) Hansch analysis with verapamil derivatives of group A (= different substitution of the benzene ring near C) shows that the variance of biological activity can be optimally correlated to a combination of the Hammett constant and the molar volume. Hansch analysis of group B (= exchange of isopropyl group) led to the conclusion that hydrophobic effects are responsible for the influence of the isopropyl substituent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 652064     DOI: 10.1007/BF00517988

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  "Aromatic" substituent constants for structure-activity correlations.

Authors:  C Hansch; A Leo; S H Unger; K H Kim; D Nikaitani; E J Lien
Journal:  J Med Chem       Date:  1973-11       Impact factor: 7.446

2.  Change correlations in structure-activity studies using multiple regression analysis.

Authors:  J G Topliss; R J Costello
Journal:  J Med Chem       Date:  1972-10       Impact factor: 7.446

3.  Interdependence between physical parameters and selection of substituent groups for correlation studies.

Authors:  P N Craig
Journal:  J Med Chem       Date:  1971-08       Impact factor: 7.446

4.  The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics.

Authors:  C Hansch; A R Steward; S M Anderson; D Bentley
Journal:  J Med Chem       Date:  1968-01       Impact factor: 7.446

5.  On the parabolic relationship between drug potency and hydrophobicity.

Authors:  J W McFarland
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

6.  Comparison of parameters currently used in the study of structure-activity relationships.

Authors:  A Leo; C Hansch; C Church
Journal:  J Med Chem       Date:  1969-09       Impact factor: 7.446

7.  On model building in structure-activity relationships. A reexamination of adrenergic blocking activity of beta-halo-beta-arylalkylamines.

Authors:  S H Unger; C Hansch
Journal:  J Med Chem       Date:  1973-07       Impact factor: 7.446

8.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

9.  Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. I. Pattern of inotropic effects of the racemic compounds.

Authors:  R Bayer; R Hennekes; R Kaufmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers.

Authors:  R Bayer; R Kaufmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

View more
  9 in total

1.  Synthesis and study of new paramagnetic and diamagnetic verapamil derivatives.

Authors:  Balázs Bognár; Shabnam Ahmed; M Lakshmi Kuppusamy; Karuppaiyah Selvendiran; Mahmood Khan; József Jeko; Olga H Hankovszky; Tamás Kálai; Periannan Kuppusamy; Kálmán Hideg
Journal:  Bioorg Med Chem       Date:  2010-02-25       Impact factor: 3.641

2.  Structure-activity studies on nifedipine in isolated cardiac muscle.

Authors:  R Rodenkirchen; R Bayer; R Steiner; F Bossert; H Meyer; E Möller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Calcium ions modulate hormonally stimulated progesterone production in isolated ovarian cells.

Authors:  J D Veldhuis; P A Klase
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

4.  Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors.

Authors:  D Pelzer; W Trautwein; T F McDonald
Journal:  Pflugers Arch       Date:  1982-08       Impact factor: 3.657

5.  Verapamil block of T-type calcium channels.

Authors:  Pamela Bergson; Gregory Lipkind; Steven P Lee; Mark-Eugene Duban; Dorothy A Hanck
Journal:  Mol Pharmacol       Date:  2010-12-13       Impact factor: 4.436

6.  Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.

Authors:  J Striessnig; H G Knaus; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

7.  Structural model for phenylalkylamine binding to L-type calcium channels.

Authors:  Ricky C K Cheng; Denis B Tikhonov; Boris S Zhorov
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

8.  Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?

Authors:  J Hescheler; D Pelzer; G Trube; W Trautwein
Journal:  Pflugers Arch       Date:  1982-06       Impact factor: 3.657

9.  (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.

Authors:  D R Ferry; A Goll; C Gadow; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.